Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketamine for Pediatric Procedural Sedation
NCT03067974Phase 1Terminated
- Sponsor
- University of Arizona
- Start
- Sep 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in Procedural sedation (PS), sponsored by University of Arizona. Primary endpoint: Successful procedural sedation. Started Sep 2017; status: terminated.
02
Drugs
ketamine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT03067974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067974.